CLINICAL_TRIALS
trial_result
· 2022-05-18
Clinical Trial Update: Using Doxepin for Urticaria [Phase 3]
Summary
Phase 3 trial investigating doxepin for urticaria is in progress with unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: State University of New York - Upstate Medical University | Conditions: Urticaria | Phase 3 | Status: UNKNOWN